<code id='146B5B494D'></code><style id='146B5B494D'></style>
    • <acronym id='146B5B494D'></acronym>
      <center id='146B5B494D'><center id='146B5B494D'><tfoot id='146B5B494D'></tfoot></center><abbr id='146B5B494D'><dir id='146B5B494D'><tfoot id='146B5B494D'></tfoot><noframes id='146B5B494D'>

    • <optgroup id='146B5B494D'><strike id='146B5B494D'><sup id='146B5B494D'></sup></strike><code id='146B5B494D'></code></optgroup>
        1. <b id='146B5B494D'><label id='146B5B494D'><select id='146B5B494D'><dt id='146B5B494D'><span id='146B5B494D'></span></dt></select></label></b><u id='146B5B494D'></u>
          <i id='146B5B494D'><strike id='146B5B494D'><tt id='146B5B494D'><pre id='146B5B494D'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:2816
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more
          New guidelines on severe brain injury complicate already difficult decisions
          New guidelines on severe brain injury complicate already difficult decisions

          AdobeWhensomeonesustainsaseriousbraininjuryandisunresponsive,howsooncandoctorssaywhetherheorshehasac

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          PBM executives asked to testify by House panel

          Rep.JamesComer(R-Ky.),thechairoftheHouseCommitteeonOversightandAccountability,hastakenaninterestinph